In the ccRCC patients, reduced expression of AOX1 predicts worse overall survival, and the predictive value is further supported by the target–disease association analysis of AOX1, which identified more than 20 kinds of cancers as its potentially relevant diseases including ccRCC. This evidence concerns the gene AOX1 and nonpapillary renal cell carcinoma.